SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001375151-21-000093
Filing Date
2021-11-04
Accepted
2021-11-04 16:11:22
Documents
13
Period of Report
2021-11-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zgnx-20211104.htm   iXBRL 8-K 37963
2 EX-99.1 zgnx-2021q3erexx991.htm EX-99.1 126081
  Complete submission text file 0001375151-21-000093.txt   317381

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zgnx-20211104.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zgnx-20211104_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zgnx-20211104_pre.xml EX-101.PRE 13044
6 EXTRACTED XBRL INSTANCE DOCUMENT zgnx-20211104_htm.xml XML 11504
Mailing Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 500 EMERYVILLE CA 94608 (510) 550-8300
ZOGENIX, INC. (Filer) CIK: 0001375151 (see all company filings)

IRS No.: 205300780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34962 | Film No.: 211380041
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences